Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
AstraZeneca
Accenture
Boehringer Ingelheim
Federal Trade Commission
QuintilesIMS

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 9,725,716

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,725,716
Title:Non-ionic, low osmolar contrast agents for delivery of antisense oligonucleotides and treatment of disease
Abstract: Disclosed are compositions comprising an antisense oligonucleotide and a non-ionic, low-osmolar contrast agent. Also disclosed are methods of delivering an antisense oligonucleotide to a target sire comprising incorporating the antisense oligonucleotide into a composition comprising a non-ionic, low-osmolar contrast agent. Also disclosed are methods of treating a neurodegenerative disease comprising administering one or more of the compositions disclosed herein.
Inventor(s): Burghes; Arthur (Columbus, OH), Porensky; Paul (Worthington, OH), Kaspar; Brian (New Albany, OH)
Assignee: Ohio State Innovation Foundation and Research Institute at Nationwide Children\'s Hospital (Columbus, OH)
Application Number:14/363,670
Patent Claims:see list of patent claims

Details for Patent 9,725,716

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Ohio State Innovation Foundation and Research Institute at Nationwide Children\'s Hospital (Columbus, OH) 2032-12-06 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Ohio State Innovation Foundation and Research Institute at Nationwide Children\'s Hospital (Columbus, OH) 2032-12-06 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Ohio State Innovation Foundation and Research Institute at Nationwide Children\'s Hospital (Columbus, OH) 2032-12-06 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Argus Health
McKesson
Fuji
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.